Volume : 11, Issue : 06, June – 2024
Title:
FORMULATION AND EVALUATION OF AYURVEDIC HYPERTENSION TABLET
Authors :
Vishal Ramsing Suradkar, Avinash G. Wagh
Abstract :
Hypertension, a prevalent cardiovascular disorder, is often managed through conventional pharmacological interventions, which may have adverse effects. This study focuses on the development and evaluation of an ayurvedic tablet formulation for hypertension, utilizing natural ingredients renowned for their antihypertensive properties. The formulation comprises a blend of herbal extracts including Terminalia arjuna, Rauwolfia serpentina, and Withania somnifera, selected based on traditional ayurvedic texts and contemporary scientific validation.
The tablets were prepared using the wet granulation method, followed by comprehensive physicochemical characterization, including hardness, friability, disintegration time, and dissolution profile. Stability studies were conducted to ensure the formulation’s shelf life. In vivo efficacy was assessed using an induced hypertensive model in rats, with blood pressure measurements taken over a specified period.
The results indicated that the ayurvedic tablet formulation significantly reduced blood pressure without adverse effects, demonstrating potential as a natural alternative for hypertension management. Further clinical studies are recommended to confirm these findings and establish dosage guidelines for human use.
Cite This Article:
Please cite this article in press Vishal Ramsing Suradkar et al., Formulation And Evaluation Of Ayurvedic Hypertension Tablet .,Indo Am. J. P. Sci, 2024; 11 (6).
Number of Downloads : 10
References:
1. Dipak P. Mali1, Snehal P. Kamble , Dinanath T. Gaikwad , Ganesh H. Wadkar , Mangesh A. Bhutkar , Firoj A. Tamboli, Vijaykumar T. Pawar. Standardization and Evaluation of Herbal Antihypertensive Sarpagandha (Reserpine) Tablet Formulations 2023
2. Hari khanal, Ram kishor joshi, abhishek upadhyay, anti-hypertensive activity of ayurvedic medicinal plants, Int J Complement alt med. 2020;13(1):7-12
3. The pharma innovation journal 2016;5(1):14-18
4. Granulation , presented by sajjad ahmed Lachmann L, Liberman HA, Schwartz JB. Pharmaceutical Dosage Forms. New York: Marcel DekkerInc, 1989, 2(1).
5. L. Lachman, H. A. Liberman and L. J. Kanig. Theory and Practice of Industrial Pharmacy. 3rd edition. Vargese publication house, New Delhi, 1990; 231-234.
6. B. Haritha. Journal of formulation science and Bio availability. Research and Reviews, 2017; 1(1): 1-7.
7. A. Martin, J. Swarbrick and A. Cammarata. Physical Pharmacy. 2nd edition, Wolters Kluwer, USA, 1983; 532-533, 513- 51.
8. B. Nitin and S. Govind. Formulation and evaluation of orally disintegrating tablets of Ondansetron hydrochloride using natural superdisintegrants. International Journal of Pharmaceutical Technology and Research, 2011; 3(3); 1616-1621.
9. Gregory E. Amidon, Pamela J. Secreast and Deanna Muddie. Practical, powder and compact characterization. In: Yihong Qui, Yisheng chen, Geoff GZ Zhang, editors. Developing solid oral dosage
10. Mohammad Asad, S. Dwivedi* and S.K. Jain* , Case study Compatibility of Terminalia arjuna (Roxb.) Wight & Arn. with common cardiovascular drugs, Annals of Phytomedicine 5(2): 45- 49, 2016,
11. Subir K. Maulik1 and Kewal K. Talwar2, Therapeutic Potential of Terminalia Arjuna in Cardiovascular Disorders , Am J Cardiovasc Drugs 2012; 12 (3): 157-163
12. Asha Kesari, Herbal Anti Hypertension Drugs, PharmaTutor; 2014; 2(12); 49-61
13. Gunjan G. Hedaoo, Dr. S. M. Mular and Dr. Z. H. Khan*, EXTRACTION AND PHYTOCHEMICAL ANALYSIS OF TERMINALIA ARJUNA, ejbps, 2016, Volume 3, Issue 5, 507-509